Medications for Irritable Bowel Syndrome (IBS)
The treatment of IBS should follow a stepwise approach, starting with dietary modifications and first-line medications (laxatives for constipation, antidiarrheals for diarrhea, and antispasmodics for pain), followed by second-line treatments based on predominant symptoms. 1
First-Line Pharmacological Treatments
For IBS with Diarrhea (IBS-D)
- Antidiarrheals:
For IBS with Constipation (IBS-C)
- Laxatives:
For Abdominal Pain (All IBS subtypes)
- Antispasmodics:
Second-Line Pharmacological Treatments
For IBS-D
- FDA-approved medications:
- Other options:
For IBS-C
- Secretagogues:
For Pain and Psychological Symptoms
- Neuromodulators:
- Tricyclic antidepressants (TCAs): Amitriptyline 10-50 mg at bedtime for pain with sleep disturbance 2, 1
- Selective serotonin reuptake inhibitors (SSRIs): For predominant anxiety/depression, though less effective for pain 1
- Serotonin-norepinephrine reuptake inhibitors (SNRIs): Duloxetine for visceral pain 1
- Mirtazapine: For refractory nausea and vomiting 1
Treatment Algorithm
Start with dietary modifications and lifestyle changes
Add soluble fiber and/or peppermint oil
If inadequate response:
- For IBS-C: Add polyethylene glycol
- For IBS-D: Add loperamide
If still inadequate response:
- For IBS-C: Add a secretagogue (linaclotide preferred)
- For IBS-D: Consider rifaximin or eluxadoline
For persistent symptoms:
- Add an antispasmodic or gut-brain neuromodulator (TCAs, SSRIs)
For severe or refractory symptoms:
- Consider psychological therapies (cognitive-behavioral therapy, gut-directed hypnotherapy) 1
Important Considerations
- Complete symptom resolution is often not achievable, and this must be made clear to patients to manage expectations 2
- The efficacy of all drugs for IBS treatment is modest, including newer drugs developed specifically for IBS 2
- Use a symptom diary to identify triggers and monitor response to treatment 1
- Review efficacy after 3 months of treatment and discontinue if no response 1
Caveats and Pitfalls
- Avoid using TCAs in patients with constipation as they may worsen this symptom
- SSRIs may exacerbate diarrhea in some patients with IBS-D
- Rifaximin should not be used for systemic bacterial infections due to limited systemic exposure after oral administration 4
- Eluxadoline should be used with caution in patients with a history of pancreatitis or alcohol abuse
- Patients with hepatic impairment may require dose adjustments for rifaximin, as exposure is significantly higher in these patients 4